The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Aclaris Therapeutics Inc shares valued at $1,499,998 were purchased by Mehra Anand on Nov 19 ’24. At $2.25 per share, Mehra Anand acquired 666,666 shares. The insider’s holdings grew to 710,030 shares worth approximately $1.09 million following the completion of this transaction.
Also, Leonard Braden Michael purchased 206,025 shares, netting a total of over 256,357 in proceeds. Following the buying of shares at $1.24 each, the insider now holds 14,250,000 shares.
Before that, Leonard Braden Michael had added 167,544 shares to its account. In a trade valued at $216,400, the 10% Owner bought Aclaris Therapeutics Inc shares for $1.29 each. Upon closing the transaction, the insider’s holdings increased to 167,544 shares, worth approximately $21.63 million.
Analysts at H.C. Wainwright upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in late December. As of November 20, 2024, Cantor Fitzgerald has increased its “Neutral” rating to a “an Overweight” for ACRS. Earlier on November 19, 2024, Leerink Partners upgraded its rating. Their new recommendation was “an Outperform” for ACRS stock which previously was a “a Market perform”.
Analyzing ACRS Stock Performance
During the last five days, there has been a drop of approximately -4.94%. Over the course of the year, Aclaris Therapeutics Inc shares have dropped approximately -37.90%. Shares of the company reached a 52-week high of $2.7950 on 01/03/25 and a 52-week low of $1.4600 on 04/02/25. A 50-day SMA is recorded $2.0158, while a 200-day SMA reached $1.9018.
Support And Resistance Levels for Aclaris Therapeutics Inc (ACRS)
According to the 24-hour chart, there is a support level at 1.4733, which, if violated, would cause prices to drop to 1.4067. In the upper region, resistance lies at 1.5933. The next price resistance is at 1.6467. RSI (Relative Strength Index) is 33.57 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0683, which suggests the price will decrease in the coming days. Percent R is at 74.60%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
